These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 17565632

  • 1. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL, de Silva HJ, Leung NW, Lim SG, Farrell GC, Asia-Pacific Working Party on NAFLD.
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [Abstract] [Full Text] [Related]

  • 2. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.
    Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD, Asia-Pacific Working Party on NAFLD.
    J Gastroenterol Hepatol; 2007 Jun; 22(6):778-87. PubMed ID: 17565630
    [Abstract] [Full Text] [Related]

  • 3. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A, Asia-Pacific Working Party for NAFLD.
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [Abstract] [Full Text] [Related]

  • 4. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary.
    Farrell GC, Chitturi S, Lau GK, Sollano JD, Asia-Pacific Working Party on NAFLD.
    J Gastroenterol Hepatol; 2007 Jun; 22(6):775-7. PubMed ID: 17565629
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
    Federico A, Trappoliere M, Loguercio C.
    Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
    [Abstract] [Full Text] [Related]

  • 6. [Non-alcoholic fatty liver].
    Tagle Arrospide M.
    Rev Gastroenterol Peru; 2003 Nov; 23(1):49-57. PubMed ID: 12768215
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The clinical aspects of non-alcoholic fatty liver disease.
    Björnsson E.
    Minerva Gastroenterol Dietol; 2008 Mar; 54(1):7-18. PubMed ID: 18299664
    [Abstract] [Full Text] [Related]

  • 9. Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.
    Lebovics E, Rubin J.
    Diabetes Metab Res Rev; 2011 Jul; 27(5):419-24. PubMed ID: 21425426
    [Abstract] [Full Text] [Related]

  • 10. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 11. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A, Bauman A, Johnston A, Farrell G, Chey T, George J.
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [Abstract] [Full Text] [Related]

  • 12. Non-alcoholic fatty liver disease from pathogenesis to management: an update.
    Musso G, Gambino R, Cassader M.
    Obes Rev; 2010 Jun; 11(6):430-45. PubMed ID: 19845871
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
    Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De Silva AP, Makaya M, Mizoue T, Kato N, Wickremasinghe AR, de Silva HJ.
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
    [Abstract] [Full Text] [Related]

  • 14. Non-alcoholic fatty liver disease: the mist gradually clears.
    de Alwis NM, Day CP.
    J Hepatol; 2008 Jul; 48 Suppl 1():S104-12. PubMed ID: 18304679
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic evaluation of nonalcoholic fatty liver disease.
    Adams LA, Talwalkar JA.
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S34-8. PubMed ID: 16540765
    [Abstract] [Full Text] [Related]

  • 16. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 17. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H, Gonzalez JL, Márquez-Ramirez MD, Flores-Hernandez M, Rodríguez-Morán M, Guerrero-Romero F.
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [Abstract] [Full Text] [Related]

  • 18. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.
    Cortez-Pinto H, Camilo ME.
    Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1089-104. PubMed ID: 15561640
    [Abstract] [Full Text] [Related]

  • 19. Nonalcoholic fatty liver disease.
    Angulo P.
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
    [Abstract] [Full Text] [Related]

  • 20. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM, Ostapowicz G, Weltman MD.
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.